文献速递肝病消化道肿瘤与早癌

CCL15招募抑制性单核细胞促进肝细胞癌免疫逃逸与疾病进展

CCL15 Recruits Suppressive Monocytes to Facilitate Immune Escape and Disease Progression in Hepatocellular Carcinoma.
PubMed 文献 · Hepatology · 2018-12-31

该研究通过检测肝细胞癌细胞系与组织中趋化因子表达,发现CCL15在人类肝细胞癌中表达最丰富,受遗传、表观遗传及微环境因素调控,且与患者临床结局负相关。CCL15以自分泌方式促进肿瘤侵袭,并特异性招募CCR1+细胞至肝癌浸润边缘,其中约80%为CD14+单核细胞。边缘高密度CCR1+CD14+单核细胞与CCL15表达正相关,为不良生存的独立指标,这些单核细胞通过释放促瘤因子及激活STAT1/3、ERK1/2、AKT信号加速肿瘤侵袭转移,并高表达PD-L1、B7-H3、TIM-3等免疫检查点分子,转录组测序证实其上调免疫检查点、免疫耐受代谢酶及促血管生成因子等。原位动物模型证实CCL15-CCR1轴塑造富集CCR1+单核细胞的炎性微环境并增加转移潜能。结论认为CCL15-CCR1轴塑造促瘤炎性微环境,阻断该轴可能成为有效抗癌疗法。

要点

  • CCL15是 human HCC 中表达最丰富的趋化因子,与患者临床结局负相关。
  • CCL15通过CCR1招募CD14+单核细胞至肿瘤浸润边缘,约80%为CD14+单核细胞。
  • 边缘CCR1+CD14+单核细胞高密度为不良生存独立指标,并促进侵袭转移与免疫抑制。

核心结论

  • CCL15-CCR1轴在人类肝细胞癌中塑造复杂的促瘤炎性微环境。
  • 阻断CCL15-CCR1轴可能成为有效的抗癌疗法(作者认为)。

研究设计与样本

  • 研究检测肝细胞癌细胞系与组织中全部趋化因子的表达,并分析CCL15的调控因素与临床相关性。
  • 采用原位动物模型验证CCL15-CCR1轴的作用,并对肿瘤浸润CCR1+CD14+单核细胞进行转录组测序。

主要发现

  • CCL15在人类肝细胞癌中表达最丰富,受遗传、表观遗传和微环境因素调控,与患者临床结局负相关。
  • CCL15以自分泌方式促进肿瘤侵袭,并特异性招募CCR1+细胞至肝癌浸润边缘,其中约80%为CD14+单核细胞。
  • 边缘高密度CCR1+CD14+单核细胞与CCL15表达正相关,为不良生存的独立指标。
  • 这些单核细胞通过释放多种促瘤因子并激活STAT1/3、ERK1/2和AKT信号直接加速肿瘤侵袭转移。
  • 肿瘤来源CCR1+CD14+单核细胞显著高表达PD-L1、B7-H3和TIM-3,可能导致免疫抑制。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Chemokines play a key role in orchestrating the recruitment and positioning of myeloid cells within the tumor microenvironment. However, the tropism regulation and functions of these cells in hepatocellular carcinoma (HCC) are not completely understood. Herein, by scrutinizing the expression of all chemokines in HCC cell lines and tissues, we found that CCL15 was the most abundantly expressed chemokine in human HCC. Further analyses showed that CCL15 expression was regulated by genetic, epigenetic, and microenvironmental factors, and negatively correlated with patient clinical outcome. In addition to promoting tumor invasion in an autocrine manner, CCL15 specifically recruited CCR1+ cells toward HCC invasive margin, approximately 80% of which were CD14+ monocytes. Clinically, a high density of marginal CCR1+ CD14+ monocytes positively correlated with CCL15 expression and was an independent index for dismal survival. Functionally, these tumor-educated monocytes directly accelerated tumor invasion and metastasis through bursting various pro-tumor factors and activating signal transducer and activator of transcription 1/3, extracellular signal-regulated kinase 1/2, and v-akt murine thymoma viral oncogene homolog signaling in HCC cells. Meanwhile, tumor-derived CCR1+ CD14+ monocytes expressed significantly higher levels of programmed cell death-ligand 1, B7-H3, and T-cell immunoglobulin domain and mucin domain-3 that may lead to immune suppression. Transcriptome sequencing confirmed that tumor-infiltrating CCR1+ CD14+ monocytes were reprogrammed to upregulate immune checkpoints, immune tolerogenic metabolic enzymes (indoleamine and arginase), inflammatory/pro-angiogenic cytokines, matrix remodeling proteases, and inflammatory chemokines. Orthotopic animal models confirmed that CCL15-CCR1 axis forested an inflammatory microenvironment enriched with CCR1+ monocytes and led to increased metastatic potential of HCC cells. Conclusion: A complex tumor-promoting inflammatory microenvironment was shaped by CCL15-CCR1 axis in human HCC. Blockade of CCL15-CCR1 axis in HCC could be an effective anticancer therapy.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Liu LZ, Zhang Z, Zheng BH, et al. CCL15 Recruits Suppressive Monocytes to Facilitate Immune Escape and Disease Progression in Hepatocellular Carcinoma. Hepatology. 2018. PMID: 30070719. doi:10.1002/hep.30134

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。